Steven Cohen’s Calithera Biosciences, Inc CALA Stock Holding History

Steven Cohen’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-38,025	Closed	-$1.66M	–	1391
2021 Q3	$1.66M	Hold	38,025	–	–	0.01%	796
2021 Q2	$1.59M	Hold	38,025	–	–	0.01%	754
2021 Q1	$1.84M	Sell	38,025 -46,975	-55%	-$2.73M	0.01%	740
2020 Q4	$8.35M	Sell	85,000 -101,375	-54%	-$8.88M	0.04%	483
2020 Q3	$12.9M	Sell	186,375 -18,697	-9%	-$1.63M	0.07%	358
2020 Q2	$21.7M	Sell	205,072 -6,178	-3%	-$734K	0.14%	204
2020 Q1	$18.8M	Buy	211,250 +160,951	+320%	+$19.2M	0.15%	197
2019 Q4	$5.74M	Sell	50,299 -9,701	-16%	-$730K	0.03%	481
2019 Q3	$3.71M	Sell	60,000 -36,790	-38%	-$2.95M	0.02%	506
2019 Q2	$7.55M	Buy	+96,790	New	+$11M	0.04%	433

Other funds holding CALA

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Steven Cohen's CALA Position: Q4 2021 in Review

Steven Cohen sold out of Calithera Biosciences, Inc (CALA) in Q4 2021, closing a stake of 38,025 shares — an estimated $1.66M sold.

Steven Cohen first reported a position in CALA in Q2 2019 and held it in 10 quarters. The position peaked at $21.7M in Q2 2020. 55 funds tracked by Wall St. Rank hold CALA as of Q4 2021.

Steven Cohen reported no remaining Calithera Biosciences, Inc position as of Q4 2021 after selling out during the quarter.
Steven Cohen sold 38,025 Calithera Biosciences, Inc shares in Q4 2021, an estimated $1.66M.
Steven Cohen first reported a position in Calithera Biosciences, Inc in Q2 2019 and held it in 10 quarters.
Steven Cohen's Calithera Biosciences, Inc position peaked at $21.7M in Q2 2020.
55 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2021.

Based on Point72 Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.